US Patent Issued to Northwestern University on Sept. 29 for "Substituted heterocycles for treating cancer" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,243, issued on Sept. 29, was assigned to Northwestern University (Evanston, Ill.).

"Substituted heterocycles for treating cancer" was invented by Gary E. Schiltz (Evanston, Ill.) and Karl A. Scheidt (Evanston, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are substituted pyrrolo[2,3-d]pyrimidine compounds. The disclosed compounds are shown to be useful in inhibiting the growth of cancer cell lines and treating cancer and cell proliferative disorders."

The patent was filed on Aug. 24, 2023, under Application No. 18/455,206.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/n...